Skip to main content
Figure 2 | Child and Adolescent Psychiatry and Mental Health

Figure 2

From: Impact of Attention-Deficit/Hyperactivity Disorder (ADHD) on prescription dug spending for children and adolescents: increasing relevance of health economic evidence

Figure 2

Methylphenidate prescriptions trend in Germany, 1992 – 2005. Methylphenidate prescriptions grew 47-fold from 1992 to 2005. During the same period, total prescriptions in Germany declined by 41 percent. Data source: Wissenschaftliches Institut der AOK, Schwabe and Paffrath, 1993 – 2006 [20]; note change of database for year 2001/2002. All data refer to prescriptions reimbursed by statutory health insurance (SHI, "GKV", covering approximately 90 percent of German population); excluding parallel imports. Note that these data include prescriptions for adults with ADHD and also for other indications (narcolepsy).

Back to article page

Child and Adolescent Psychiatry and Mental Health

ISSN: 1753-2000